A leading investment expert forecasts a stronger year ahead for CSL shares. Let’s see why. The post 3 reasons to buy CSL ...

The offering is one of four biotech IPOs that could price by Friday, and comes during the busiest week for such activity ...

J&K Ingredients has entered a partnership with Pallas Biotech Co. Ltd., a global biotechnology company, that brings together complementary capabilities across research and development, fermentation, ...

When Impossible Foods announced that CEO Peter McGuiness would step down after nearly four years, the company framed the move as a transition “from a position of strength.” For Rachel Konrad, the ...

The FDA has granted fast track designation to the investigational oncolytic virus immunotherapy pelareorep (Reolysin) in combination with bevacizumab (Avastin) and FOLFIRI (leucovorin, fluorouracil, ...

Why is Sobi paying $950M upfront for Arthrosi? Analyze the deal terms, the $550M in milestones, and the projected growth through the 2030s.

Next, let’s go back to the second-best performer in the S&P for January, and that’s Moderna. That was up nearly 50%, and this was… a wild ride.

A major biotech company has announced plans to lay off more than 100 positions from its Franklin, Massachusetts, facility.

Novartis has nixed six early-stage pipeline programs, swapping in two new phase 1 cancer candidates as replacements. | ...

The FDA last year wanted to expedite the review of Compass Pathways’ psilocybin treatment for severe depression as part of a ...

When measured against the market's most prolific capital-return leaders, Amgen’s ability to maintain this level of ...

Stem cell therapy biotech PrimeGen US is taking the less-traveled special purpose acquisition company (SPAC) route to the ...